Skip to main content
. 2021 Oct 3;13(10):1611. doi: 10.3390/pharmaceutics13101611

Figure 6.

Figure 6

Chelidonine and Rotenone exhibit potential and selective anti-tumor activity. Data of viability and immunofluorescence assays. (A) Viability screening of candidate molecules. (B) Selective activity of Chelidonine and Rotenone against transformed fibroblast BJ-EHLT. (C) Quantitative analysis of fluorescence intensity of γH2AX signal in BJ-hTERT and BJ-EHLT. (D) Representative images of γH2AX fluorescent signal. ns, p > 0.05; *, p < 0.05; ***, p < 0.001.